C
The startup develops AI-driven live-cell imaging technology to predict and optimize stem cell differentiation, enabling the scalable manufacture of any cell or tissue in the body. This approach addresses the need for effective stem cell-based therapies for chronic diseases, facilitating data-driven drug development and improving patient outcomes.
Updated 3 months ago
Funding
$11.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops AI-driven live-cell imaging technology to predict and optimize stem cell differentiation, enabling the scalable manufacture of any cell or tissue in the body. This approach addresses the need for effective stem cell-based therapies for chronic diseases, facilitating data-driven drug development and improving patient outcomes.